Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli

Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli

Author Sader, H. S. Google Scholar
Jones, R. N. Google Scholar
Institution JMI Labs Inc
Universidade Federal de São Paulo (UNIFESP)
Tufts Univ
Abstract The frequency of occurrence and antimicrobial susceptibility patterns of 3059 non-enteric Gram-negative bacilli (NGB), other that) Pseudomonas aeruginosa and Acinetobacter spp., consecutively collected as part of the SENTRY Antimicrobial Surveillance Program (1997-2003) were reviewed. During this period, a total of 221,084 bacterial isolates were collected from several clinical specimens worldwide, including 25,305 (11.5%) NGB. Acinetobacter spp. and P. aeruginosa accounted for 82.7% of the NGB isolates and have been excluded from this analysis. the antimicrobial susceptibility results of 3509 strains from 13 species/genera have been analysed in this review. the isolates were tested by reference broth microdilution methods in three central laboratories using common reagents and procedures. More than 30 antimicrobial agents were tested and the results for the 18 most active compounds are reported here. Stenotrophomonas maltophilia (2076 strains; 59.2%) was the most frequently isolated pathogen in this group, followed by Aeromonas spp. (385 strain; 11.0%), Burkholderia cepacia (269 strains; 7.7%), Pseudomonas fluorescens/putida (253 strains; 7.2%) and Alcaligenes spp. (236 strains; 6.7%). All other species/genera accounted for less than 3% of the isolates analysed. the antimicrobial agents with the most consistent activity against the NGB evaluated in the present study were the newer fluoroquinolones gatifloxacin and levofloxacin with 84.1 and 84.9% susceptibility overall. Trimethoprim/sulphamethoxazole was active against 85.3% of the isolates tested, but showed reduced activity against P. fluorescens/putida (22.1% susceptibility). Antimicrobial susceptibility varied significantly between species/genera and the geographical regions evaluated. Thus, proper identification and quantitative susceptibility testing will be required for the treatment of NGB infections. Extensive worldwide surveillance programmes remain extremely important to guide empirical antimicrobial therapy for rarely isolated pathogens and also for pathogens that are not routinely tested due to the lack of standardised susceptibility testing methods. (C) 2004 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
Keywords gram-negative bacteria
antimicrobial resistance
SENTRY Antimicrobial Surveillance Program
non-fermentative Gram-negative bacilli
susceptibility testing
nosocomial infection
Language English
Date 2005-02-01
Published in International Journal of Antimicrobial Agents. Amsterdam: Elsevier B.V., v. 25, n. 2, p. 95-109, 2005.
ISSN 0924-8579 (Sherpa/Romeo, impact factor)
Publisher Elsevier B.V.
Extent 95-109
Origin http://dx.doi.org/10.1016/j.ijantimicag.2004.10.002
Access rights Closed access
Type Review
Web of Science ID WOS:000227016700001
URI http://repositorio.unifesp.br/handle/11600/28136

Show full item record




File

File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search


Browse

Statistics

My Account